Keyword: Bristol-Myers Squibb (BMS)
News
23.04.2012
- AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster its weak pipeline in a deal that feeds a wave of M&A in the...
News
09.04.2012
- Carl Icahn sued Amylin Pharmaceuticals on Monday to extend a deadline for nominating directors, as the activist investor pushes to win enough board seats to engineer a sale of the...
News
02.04.2012
- In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research...
News
28.03.2012
- Shares of Amylin Pharmaceuticals rose as much as 51% on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers...
News
15.03.2012
- German chemicals and drugs group Bayer expects higher profit margins and sales at its healthcare division over the next three years, where product launches are set to boost...
News
22.09.2011
- Bristol-Myers Squibb and Ambrx announced a collaboration under which Bristol-Myers will receive exclusive worldwide rights to research, develop and commercialize biologics based on...
News
09.09.2011
- Bristol-Myers Squibb said Thursday that it has completed its acquisition of privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery...
News
29.07.2011
- Bristol-Myers Squibb reported Thursday a profit for the second quarter that declined from last year, hurt by higher restructuring and licensing charges. However, sales of company's...
